BCG Vaccination in HIV-Infected Children
Joint Authors
Nuttall, James J. C.
Eley, Brian S.
Source
Tuberculosis Research and Treatment
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-04-10
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Despite the use of Bacillus Calmette-Guérin (BCG) vaccination for many years, infants and young children exposed to adults with infectious forms of tuberculosis (TB) are at high risk of developing complicated TB disease.
This risk is much higher among HIV-infected children, and data on BCG protective efficacy in HIV-infected children is lacking.
Recent research on BCG safety in HIV-infected infants has resulted in policy shifts, but implementation is challenging.
New approaches to preventing TB among infants and children, particularly HIV-infected infants, are needed.
This paper briefly reviews BCG safety and efficacy considerations in HIV-infected infants and discusses other approaches to preventing TB, including new TB vaccines and vaccination strategies.
American Psychological Association (APA)
Nuttall, James J. C.& Eley, Brian S.. 2011. BCG Vaccination in HIV-Infected Children. Tuberculosis Research and Treatment،Vol. 2011, no. 2011, pp.1-6.
https://search.emarefa.net/detail/BIM-492564
Modern Language Association (MLA)
Nuttall, James J. C.& Eley, Brian S.. BCG Vaccination in HIV-Infected Children. Tuberculosis Research and Treatment No. 2011 (2011), pp.1-6.
https://search.emarefa.net/detail/BIM-492564
American Medical Association (AMA)
Nuttall, James J. C.& Eley, Brian S.. BCG Vaccination in HIV-Infected Children. Tuberculosis Research and Treatment. 2011. Vol. 2011, no. 2011, pp.1-6.
https://search.emarefa.net/detail/BIM-492564
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-492564
